Physician profile
James D Alfandre
NPI 1568430577
$1,375.75
in general payments reported to CMS, 2019-2025
11 companies · $53.69 in 2025
The $53.69 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $56.17 · 2021: $237 · 2022: $349 · 2023: $274 · 2024: $271 · 2025: $53.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $598.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $492.20 | 2021-2024 | Tornier Flex, Adapt, Inspace |
| Zimmer Biomet Holdings, INC. | $378.52 | 2019-2024 | Comprehensive Shoulder System, Identity, Biowick X |
| Prodigy Surgical Distribution, INC. | $152.02 | 2023 | |
| Smith+Nephew, INC. | $123.69 | 2022-2023 | Biosure |
| Depuy Synthes Sales INC. | $84.83 | 2022-2024 | Truespan Orthocord, Inhance |
| Medical Device Business Services, INC. | $40.41 | 2024 | Fms |
| Bioventus LLC | $33.29 | 2022 | |
| Globus Medical, INC. | $26.95 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $26.74 | 2025 | |
| Vericel Corporation | $15.66 | 2019 | |
| Spr Therapeutics, INC | $1.44 | 2024 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Alfandre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.